Cargando…

SARS‐CoV‐2 infection as a trigger of humoral response against apolipoprotein A‐1

BACKGROUND: Unravelling autoimmune targets triggered by SARS‐CoV‐2 infection may provide crucial insights into the physiopathology of the disease and foster the development of potential therapeutic candidate targets and prognostic tools. We aimed at determining (a) the association between anti‐SARS‐...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pagano, Sabrina, Yerly, Sabine, Meyer, Benjamin, Juillard, Catherine, Suh, Noémie, Le Terrier, Christophe, Daguer, Jean‐Pierre, Farrera‐Soler, Lluc, Barluenga, Sofia, Piumatti, Giovanni, Hartley, Oliver, Lemaitre, Barbara, Eberhardt, Christiane S., Siegrist, Claire‐Anne, Eckerle, Isabella, Stringhini, Silvia, Guessous, Idris, Kaiser, Laurent, Pugin, Jerome, Winssinger, Nicolas, Vuilleumier, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420318/ https://www.ncbi.nlm.nih.gov/pubmed/34324704 http://dx.doi.org/10.1111/eci.13661

Ejemplares similares

SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1
por: Pagano, S., et al.
Publicado: (2021)

Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma
por: Farrera-Soler, Lluc, et al.
Publicado: (2020)

Pseudo-Complementary G:C Base Pair for Mixed Sequence dsDNA Invasion and Its Applications in Diagnostics (SARS-CoV-2 Detection)
por: López-Tena, Miguel, et al.
Publicado: (2023)

Combining recombinase polymerase amplification and DNA‐templated reaction for SARS‐CoV‐2 sensing with dual fluorescence and lateral flow assay output
por: Farrera‐Soler, Lluc, et al.
Publicado: (2022)

Autoantibodies against apolipoprotein A‐1 after COVID‐19 predict symptoms persistence
por: L’Huillier, Arnaud G., et al.
Publicado: (2022)

Association of Trace Element Levels with Outcomes in Critically Ill COVID-19 Patients
por: Wozniak, Hannah, et al.
Publicado: (2023)

Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence
por: L'Huillier, A.G., et al.
Publicado: (2022)

DNA display of fragment pairs as a tool for the discovery of novel biologically active small molecules
por: Daguer, J.-P., et al.
Publicado: (2015)

Auto-antibodies against apolipoprotein A-1 block cancer cells proliferation and induce apoptosis
por: Satta, Nathalie, et al.
Publicado: (2020)

Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence Settings
por: Andrey, Diego O., et al.
Publicado: (2021)

Validation of a commercially available SARS-CoV-2 serological immunoassay
por: Meyer, B., et al.
Publicado: (2020)

Socioeconomic inequalities in sport participation: pattern per sport and time trends – a repeated cross-sectional study
por: Richard, Viviane, et al.
Publicado: (2023)

Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests
por: Andrey, Diego O., et al.
Publicado: (2020)

Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance
por: Perez-Saez, Javier, et al.
Publicado: (2021)

Insights into household transmission of SARS-CoV-2 from a population-based serological survey
por: Bi, Qifang, et al.
Publicado: (2021)

Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseases
por: Lamacchia, Celine, et al.
Publicado: (2023)

Associations between Depression and Self-Reported COVID-19 Symptoms among Adults: Results from Two Population-Based Seroprevalence Studies in Switzerland
por: Piumatti, Giovanni, et al.
Publicado: (2022)

Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study
por: Richard, Aude, et al.
Publicado: (2021)

Socioeconomically Disadvantaged Neighborhoods Face Increased Persistence of SARS-CoV-2 Clusters
por: De Ridder, David, et al.
Publicado: (2021)

Geospatial digital monitoring of COVID-19 cases at high spatiotemporal resolution
por: De Ridder, David, et al.
Publicado: (2020)

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
por: Stringhini, Silvia, et al.
Publicado: (2020)

Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study
por: Pagano, Sabrina, et al.
Publicado: (2023)

Definition of Human Apolipoprotein A-I Epitopes Recognized by Autoantibodies Present in Patients with Cardiovascular Diseases
por: Teixeira, Priscila Camillo, et al.
Publicado: (2014)

Identification of a Covalent Importin-5 Inhibitor, Goyazensolide, from a Collective Synthesis of Furanoheliangolides
por: Liu, Weilong, et al.
Publicado: (2021)

Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection
por: Perez-Saez, Javier, et al.
Publicado: (2023)

The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?
por: Pagano, Sabrina, et al.
Publicado: (2015)

Health-related biological and non-biological consequences of forgoing healthcare for economic reasons
por: Petrovic, Dusan, et al.
Publicado: (2021)

Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms
por: Antiochos, Panagiotis, et al.
Publicado: (2017)

Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?
por: Bridge, Simon H., et al.
Publicado: (2018)

Determinants of adolescents’ Health-Related Quality of Life and psychological distress during the COVID-19 pandemic
por: Dumont, Roxane, et al.
Publicado: (2022)

Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population
por: Vuilleumier, Nicolas, et al.
Publicado: (2020)

Health Insurance Deductibles and Health Care–Seeking Behaviors in a Consumer-Driven Health Care System With Universal Coverage
por: Sandoval, José Luis, et al.
Publicado: (2021)

Anti‐SARS‐CoV‐2 mRNA vaccines as inducers of humoral response against apolipoprotein A‐1?
por: Vuilleumier, Nicolas, et al.
Publicado: (2021)

Serum Level of Cytokeratin 18 (M65) as a Prognostic Marker of High Cardiovascular Disease Risk in Individuals with Non-Alcoholic Fatty Liver Disease
por: Pagano, Sabrina, et al.
Publicado: (2023)

Thirteen-year trends in the prevalence of diabetes according to socioeconomic condition and cardiovascular risk factors in a Swiss population
por: de Mestral, Carlos, et al.
Publicado: (2020)

Size and duration of COVID-19 clusters go along with a high SARS-CoV-2 viral load: A spatio-temporal investigation in Vaud state, Switzerland
por: Ladoy, Anaïs, et al.
Publicado: (2021)

Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva
por: Bouman, Judith A., et al.
Publicado: (2022)

The Molecular Chaperone Hsp90α Is Required for Meiotic Progression of Spermatocytes beyond Pachytene in the Mouse
por: Grad, Iwona, et al.
Publicado: (2010)

Body height in adult women and men in a cross-sectional population-based survey in Geneva: temporal trends, association with general health status and height loss after age 50
por: Schäppi, Julia, et al.
Publicado: (2022)

Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)
por: Meyer, Benjamin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m6098ursnsgn1u5fsjj5fah6db